Status:
COMPLETED
A New Tool for Assessing Fatigue in Individuals With Advanced Cancer
Lead Sponsor:
University of Alberta
Conditions:
Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Fatigue is a common problem in advanced cancer and palliative care. The development of tools to measure fatigue, however, has been slowed by their inability to distinguish between fatigue and other re...
Detailed Description
Based on a series of qualitative studies, our group is developing a new rapid fatigue assessment screening tool (rFAST) for use with individuals who have advanced cancer and are receiving care in eith...
Eligibility Criteria
Inclusion
- Patients with advanced cancer currently receiving treatment for either hematologic or lung cancer at the Jewish General Hospital in Montreal, or patients with advanced cancer currently receiving care through the Alberta Cancer Board (Cross Cancer Institute or Tom Baker Cancer Centre), or the palliative care programs associated with the regional health authority in Edmonton, Alberta who are at least 18 years old, able to read and write English, have a Folstein Mini Mental Status Exam score of at least 22.
Exclusion
- Patients unable to give informed consent in English.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00428675
Start Date
October 1 2005
End Date
October 1 2010
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Nursing, University of Alberta
Edmonton, Alberta, Canada, T6G 2T4